跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TREPULMIX 2,5 mg/ml SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TREPULMIX 2,5 mg/ml SOLUCION PARA PERFUSION
Approved
STANDARD
TREPULMIX 2,5 mg/ml SOLUCION PARA PERFUSION
Scipharm S.À.R.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 7, 2021
Approval ID
9bbcec4976a96d0e
Company
Scipharm S.À.R.L.
Type
Standard
Approval Details
Approval Id
9bbcec4976a96d0e
Drug Cima Aemps Name
TREPULMIX 2,5 mg/ml SOLUCION PARA PERFUSION
Register Number
1191419002
Holder Company Name
Scipharm S.À.R.L.
Marketing Company Name
Aop Orphan Pharmaceuticals Iberia, S.L.U
Authorization Date
2021-04-07
Dosage Form
SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Scipharm S.À.R.L.
Active Ingredients
TREPROSTINILO SODICO
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 7, 2021
Approval ID
9bbcec4976a96d0e
Type
Standard
Back to CIMA-AEMPS Approvals
